Ruoqin Wang

880 total citations
12 papers, 667 citations indexed

About

Ruoqin Wang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruoqin Wang has authored 12 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruoqin Wang's work include Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ruoqin Wang is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ruoqin Wang collaborates with scholars based in China and United States. Ruoqin Wang's co-authors include Tongguo Shi, Weichang Chen, Shenghua Zhan, Yanchao Ma, Guangbo Zhang, Hongya Wu, Xueguang Zhang, Lei Cao, Guangbo Zhang and Xueguang Zhang and has published in prestigious journals such as European Journal of Pharmacology, Cell Death and Disease and Cancer Science.

In The Last Decade

Ruoqin Wang

11 papers receiving 666 citations

Peers

Ruoqin Wang
Shucai Yang China
Qiuyang Chen China
Marina Bacci Italy
Yueling Liao China
Yuan Meng China
Junyong Weng China
Mikako Nishida Japan
Tzu‐Yang Weng Taiwan
Bo Yin China
Tao Pan China
Shucai Yang China
Ruoqin Wang
Citations per year, relative to Ruoqin Wang Ruoqin Wang (= 1×) peers Shucai Yang

Countries citing papers authored by Ruoqin Wang

Since Specialization
Citations

This map shows the geographic impact of Ruoqin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoqin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoqin Wang more than expected).

Fields of papers citing papers by Ruoqin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoqin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoqin Wang. The network helps show where Ruoqin Wang may publish in the future.

Co-authorship network of co-authors of Ruoqin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoqin Wang. A scholar is included among the top collaborators of Ruoqin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoqin Wang. Ruoqin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wu, Jie, Qiwen Chen, Yunliang Wang, et al.. (2024). LINC01977 promotes colorectal cancer growth and metastasis by enhancing aerobic glycolysis via the ERK/c-Myc axis. Journal of Gastrointestinal Oncology. 15(1). 271–285. 5 indexed citations
2.
Zhou, Lei, Weigang Zhang, Jin Liu, et al.. (2023). A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model. Journal of Gastrointestinal Oncology. 14(3). 1504–1524. 3 indexed citations
3.
Chen, Yuqi, Wenying Yan, Yanjun Chen, et al.. (2023). Integrated multi-dimensional analysis highlights DHCR7 mutations involving in cholesterol biosynthesis and contributing therapy of gastric cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 36–36. 15 indexed citations
4.
Wang, Ruoqin, Jiayu Wang, Yanjun Chen, et al.. (2022). Circular RNA circLDLR facilitates cancer progression by altering the miR-30a-3p/SOAT1 axis in colorectal cancer. Cell Death Discovery. 8(1). 314–314. 14 indexed citations
5.
Chen, Yanjun, Jiayu Wang, Juntao Li, et al.. (2021). Astragalus polysaccharide prevents ferroptosis in a murine model of experimental colitis and human Caco-2 cells via inhibiting NRF2/HO-1 pathway. European Journal of Pharmacology. 911. 174518–174518. 125 indexed citations
6.
Wang, Ruoqin, Linqing Sun, Suhua Xia, et al.. (2021). B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway. Cell Death and Disease. 12(5). 453–453. 32 indexed citations
7.
Sun, Linqing, Juntao Li, Wenying Yan, et al.. (2021). H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis. Cancer Science. 112(6). 2245–2259. 67 indexed citations
8.
Ma, Yanchao, Ruoqin Wang, Huimin Lu, et al.. (2020). B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A. Journal of Cancer. 11(8). 2158–2170. 29 indexed citations
9.
Ma, Yanchao, Shenghua Zhan, Huimin Lu, et al.. (2020). B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death and Disease. 11(10). 824–824. 37 indexed citations
10.
Wang, Ruoqin, Yanchao Ma, Shenghua Zhan, et al.. (2020). B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Cell Death and Disease. 11(1). 55–55. 156 indexed citations
11.
Wang, Ruoqin, Tongguo Shi, & Weichang Chen. (2020). Combination Therapies with Anti-angiogenesis and B7-H3 Blockade in Cancers. 2(1).
12.
Shi, Tongguo, Yanchao Ma, Lei Cao, et al.. (2019). B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death and Disease. 10(4). 308–308. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shucai Yang Breakdown of academic impact, for papers by Qiuyang Chen Breakdown of academic impact, for papers by Marina Bacci Breakdown of academic impact, for papers by Yueling Liao Breakdown of academic impact, for papers by Yuan Meng Breakdown of academic impact, for papers by Junyong Weng Breakdown of academic impact, for papers by Mikako Nishida Breakdown of academic impact, for papers by Tzu‐Yang Weng Breakdown of academic impact, for papers by Bo Yin Breakdown of academic impact, for papers by Tao Pan
Rankless by CCL
2026